"Silicon Biotechnology" is a rapidly evolving field at the meeting point between electronics and biotechnology.
Our research focuses on interaction between biomoleculsand inorganic materials, such as silicon and asbestos.
Incollaboration with Prof. Akio Kuroda (Hiroshima University), we have been developing technologies and applications for immobilization
of proteins on silicon devices, bio-sensing, and for asbestos detection using asbestos-binding protein.
We are taking on the challenge of developing innovative applications at the cutting edge of bioscience.
Products
1. Asbester series
Asbester is an kit of reagents to detect asbestos. It is an innovative Asbestos detection
method using asbestos binding Protein.
| AIR1 | for chrysotile only | 10 tests | $ 360.00 (USD) | （code S.001-0510） |
| AIR2 | for all kinds of asbestos | 10 tests | $ 420.00 (USD) | （code S.001-2510） |
For a test using the kit, Asbester Air, a fluorescence microscopy with FITC filter set (Ex/Em=490nm/520nm) is required.
2. Portable fluorescence microscopy (iFM)
A portable fluorescence microscopy (iFM) is a light weighted and user friendly microscopy.
It can visuallize the shape and the characteristic of a target through its fluorescence properties.
It allows on-site detection of air borne asbestos with Asbester AIR kits.
| iFM | price on request |
This microscopy has a filter set (Ex/Em=490nm/520nm), suitable for FITC or other.
3. Si-tag
A method for immobilization of proteins onto the surface of silicon devices,
with the molecular orientation controlled
| Si-tag-ProteinA | 1 mg | $ 500.00 (USD) | （code S.202） |
| Si-tag-SCFV | 1 mg | ask | （code S.203） |
4. Highly sensitive ATP detection kit
Using the world's brightest luciferase (15times brighter than wild type), Luciferase FM is suitable for detction of small amount of ATP. (developed by BIOENEX Inc.)
| Luciferase FM plus | (luciferin premix) | 80 tests | $ 400.00 (USD) | （code BENX0010） |
| Luciferase FM | (enzyme only) | 1 mg | $ 330.00 (USD) | （code BENX0002） |
For more detail, please contact us at the email address, 
.
.
 |
